Confirming Autochthonous Buruli Ulcer Cases in Burkina Faso, West Africa

Autor: Nassim Hammoudi, Sylvain Godreuil, Amar Bouam, Michel Drancourt, Dezemon Zingue, Anselme Millogo

Publikováno v: American Journal of Tropical Medicine and Hygiene
American Journal of Tropical Medicine and Hygiene, 2021, 105 (3), pp.627-629. ⟨10.4269/ajtmh.20-0895⟩
Am J Trop Med Hyg

Environmental Mycobacterium ulcerans causes a disabling skin disease called Buruli ulcer. Recent studies completed the knowledge of the evolving geographic extension and epidemiology of Buruli ulcer in West Africa, where Côte d’Ivoire is reporting

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d6dd74b266690642858a982ad836a9e
https://doi.org/10.4269/ajtmh.20-0895

Treatment for Buruli ulcer: the long and winding road to antimicrobials-first

Autor: Till F. Omansen, Tjip S. van der Werf, Ymkje Stienstra

Publikováno v: The Cochrane Database of Systematic Reviews
Cochrane database of systematic reviews (Online). Wiley
ISSUE=12;ISSN=1469-493X;TITLE=Cochrane database of systematic reviews

Background Buruli ulcer is a necrotizing cutaneous infection caused by infection with Mycobacterium ulcerans bacteria that occurs mainly in tropical and subtropical regions. The infection progresses from nodules under the skin to deep ulcers, often o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bcce008a7b2e68234f593db80a2e11d
https://doi.org/10.1002/14651858.ed000128

Mycobacterium ulcerans infection (Buruli ulcer) in French Guiana, South America, 1969–2013: an epidemiological study

Autor: Sylvain Labbé, Dominique Sainte-Marie, Roger Pradinaud, Rodolphe E. Gozlan, Mathieu Nacher, Jean-François Guégan, Maylis Douine, J. Dufour, Pierre Couppié, Yann Reynaud, Christine Chevillon, Alain Berlioz-Arthaud, Marine Combe, Eric Elguero, Camilla Jensen Velvin

Publikováno v: Lancet Planetary Health
Lancet Planetary Health, Elsevier, 2017, 1 (2), pp.65-73. ⟨10.1016/S2542-5196(17)30009-8⟩
Lancet Planetary Health, 2017, 1 (2), pp.65-73. ⟨10.1016/S2542-5196(17)30009-8⟩
Lancet Planetary Health (2542-5196) (Elsevier Sci Ltd), 2017-05, Vol. 1, N. 2, P. E65-E73
The Lancet Planetary Health, Vol 1, Iss 2, Pp e65-e73 (2017)

Summary Background Mycobacterium ulcerans infection is the third most common mycobacterial disease in the world after tuberculosis and leprosy. To date, transmission pathways from its environmental reservoir to humans are still unknown. In South Amer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec6742f339c2642efca894825d25f6aa
https://www.hal.inserm.fr/inserm-01545603/document

Shaping mycolactone for therapeutic use against inflammatory disorders

Autor: Sophie Hidalgo-Lucas, Georges Bismuth, Jean-François Bisson, Laure Guenin-Macé, Sarah Saint-Auret, Cédric Tresse, Fabien Le Chevalier, Caroline Demangel, Pierre Bruhns, Ludivine Baron, Nicolas Blanchard, Friederike Jönsson, Anne-Caroline Chany

Publikováno v: Science Translational Medicine
Science Translational Medicine, 2015, 7 (289), pp.289ra85-289ra85. ⟨10.1126/scitranslmed.aab0458⟩
Science Translational Medicine, American Association for the Advancement of Science, 2015, 7 (289), pp.289ra85-289ra85. 〈10.1126/scitranslmed.aab0458〉
Science Translational Medicine, American Association for the Advancement of Science, 2015, 7 (289), pp.289ra85-289ra85. ⟨10.1126/scitranslmed.aab0458⟩

International audience; Inflammation adversely affects the health of millions of people worldwide, and there is an unmet medical need for better anti-inflammatory drugs. We evaluated the therapeutic interest of mycolactone, a polyketide-derived macro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::515e3e0e604c57dc804f3e80b4b4c2c8
https://doi.org/10.1126/scitranslmed.aab0458

Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoring

Autor: Mark Wansbrough-Jones, N'Guetta Aka, Pascal Lenormand, Ivo G. Boneca, Laure Guenin-Macé, Caroline Demangel, Fabien Le Chevalier, Romain Veyron-Churlet, Richard Phillips, Fred Stephen Sarfo, Mireille Dosso, Yaw Ampem Amoako

Publikováno v: PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Public Library of Science, 2011, 5 (7), pp.e1237. ⟨10.1371/journal.pntd.0001237⟩
PLoS Neglected Tropical Diseases, 2011, 5 (7), pp.e1237. ⟨10.1371/journal.pntd.0001237⟩
PLoS Neglected Tropical Diseases, Vol 5, Iss 7, p e1237 (2011)
PLoS Neglected Tropical Diseases; Vol 5
PLoS Neglected Tropical Diseases, Public Library of Science, 2011, 5 (7), pp.e1237. <10.1371/journal.pntd.0001237>
PLoS Neglected Tropical Diseases, Public Library of Science, 2011, 5 (7), pp.e1237. 〈10.1371/journal.pntd.0001237〉
CORE (RIOXX-UK Aggregator)
HAL-Pasteur
Digital Repository Infrastructure Vision for European Research
Hyper Article en Ligne
HAL-Inserm
DOAJ-Articles
SESAM Publication Database-FP7 HEALTH
HEALTH FP7 Publications Database
INRIA a CCSD electronic archive server
Europe PubMed Central

Background Mycobacterium ulcerans, the causative agent of Buruli ulcer (BU), is unique among human pathogens in its capacity to produce a polyketide-derived macrolide called mycolactone, making this molecule an attractive candidate target for diagnos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::045d0550e1bf99e1e25177c9105be909
https://www.hal.inserm.fr/inserm-00691438/document